Drug targets for cognitive enhancement in neuropsychiatric disorders.

Wallace, Tanya L., Ballard, Theresa M., Pouzet, Bruno, Riedel, Wim J., Wettstein, Joseph G.·2011·Pharmacology Biochemistry and Behavior
DOI 10.1016/j.pbb.2011.03.022

Cited by (127)

Items 101–127 of 127

  1. Neuroprotective Effects of Ocimum basilicum L. var. thyrsiflora on Scopolamine-Induced Non-Spatial Memory Deficits in Rats
    Nor Syafinaz Yaakob, Mohamed Ali‐Seyed, Manali Haniti Mohd-Zahid, Heng-Hui Tee, Shu-Yun Yap, Sek-Wen Ho, Yusof Kamisah, Norazrina Azmi · 2023 · Sains Malaysiana
  2. Disease association and inter-connectivity analysis of human brain specific co-expressed functional modules
    Kimin Oh, Taeho Hwang, Kihoon Cha, Gwan‐Su Yi · 2015 · Biological Research
  3. New procognitive enhancers acting at the histamine H3 and AMPA receptors reverse natural forgetting in mice: comparisons with donepezil and memantine in the object recognition task
    Caroline Louis, Karine Llopis, Laurence Danober, Fany Panayi, Pierre J. Lestage, Daniel Béracochéa · 2018 · Behavioural Pharmacology
  4. Alcohol and Developing Neuronal Circuits
    Carlos Fernando Valenzuela, Russell A. Morton · 2014 · Elsevier eBooks
  5. A Computational Analysis of the Factors Governing the Dynamics of α7 nAChR and Its Homologs
    Alican Gulsevin, Jens Meiler, Nicole A. Horenstein · 2020 · Biophysical Journal
  6. Substance Use Disorders: Cognitive Sequelae, Behavioral Manifestations, Neuroimaging Correlates, and Novel Interventions
    James Joseph Mahoney, Kirk R. Bryant, Marc W. Haut · 2019 · Springer eBooks
  7. Deciphering the concentration-dependent modulation effect of CT16 on the human α7 nicotinic receptor: Insights from molecular dynamics simulation
    Chuanbo Wang, Jinfei Mei, Mengke Jia, Sajjad Ahmad, Zijian Liu, Hongqi Ai · 2025 · ChemPhysMater
  8. Gedächtnisstörungen im Kontext neurologisch-psychiatrischer Erkrankungen
    Thorsten Bartsch, Peter Falkai · 2013 · Springer eBooks
  9. Therapeutical Potential of 5-HT6 of Receptor Modulation in Neurological and Psychiatric Conditions
    Tuolor. Rosy, Dil Prasad Subba, Debba. Farah · 2024 · International Journal of Innovative Science and Research Technology (IJISRT)
  10. Treating the Cognitive Deficits of Schizophrenia
    Bruce N. Rogers, David L. Gray · 2012 · Royal Society of Chemistry eBooks
  11. The Therapeutic Potential of the Cognitive-Enhancing Effects of Nicotine and Other Nicotinic Acetylcholine Receptor Agonists
    Britta Hahn · 2019 · Elsevier eBooks
  12. Pharmacological Assessment of Novel Phenylacetamide as a Sigma 1 Receptor Ligand
    Maninder Malik · 2014 · Digital Commons @ UNT Health Science Center
  13. SEROTONIN IN EMOTIONAL MEMORY PROCESSES: NEUROPHARMACOLOGICAL STUDIES WITH EMPHASIS ON DEPRESSION
    Therése Eriksson · 2012 · Figshare
  14. Editorial-the future of psychotropics: Did santa forget about mental illness?
    Tiffany‐Jade M. Kreys · 2012 · Mental Health Clinician
  15. Pharmakotherapie von Gedächtnisstörungen
    Gerhard Gründer · 2013 · Springer eBooks
  16. Double Dissociation of Nicotinic α7 and α4/β2 Sub-receptor Agonists for Enhancing Learning and Attentional Filtering of Distraction
    Maryzeh Azimi, Mariann Oemisch, Thilo Womelsdorf · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Role of Complementary and Alternative Medicines in Cognition and Anxiety
    Rajendra Nath · 2018 · Juniper Online Journal of Case Studies
  18. Use of Cognition to Guide Decisions About the Safety and Efficacy of Drugs in Early-Phase Clinical Trials
    Paul T. Maruff · 2019 · Handbook of behavioral neuroscience
  19. Pharmacologie des stimulants de la cognition
    Régis Bordet, Louise Carton, Julie Deguil, Thibaut Dondaine · 2019 · Elsevier eBooks
  20. IN-SILICO PRELIMINARY DOCKING SCREENING OF SOME ANTI-ALZHEIMER DRUGS
    Shweta Sharma, Kratika Daniel, V. Daniel, L Sharma · 2016 · INDIAN DRUGS
  21. Cognitive Impairment and Dementia (Mild or Major Neurocognitive Disorder) in Huntington’s Disease
    Cristina Sampaio, Beth Borowsky · 2014 · Neuropsychiatric symptoms of neurological disease
  22. References
    2014 · Elsevier eBooks
  23. Behavioral alterations in rat offspring following maternal immune activation and CXC chemokine receptor antagonism
    Stephanie A. Ballendine · 2014 · HARVEST (University of Saskatchewan)
  24. Dysfonction glutamatergique et GABAergique dans l'hippocampe après un stress immuno-inflammatoire prénatal chez le rat
    Aline Rideau Batista Novais · 2012 · theses.fr (ABES)
  25. Structural and molecular determinants of glutamate transporter allosteric modulators
    Katelyn Louise Reeb, Satyaki Saha, Xiaowei Bogetti, Adi Narayana Reddy Poli, Joseph M. Salvino, Mary Hongying Cheng, Ole Valente Mortensen, İvet Bahar, Andreia C. K. Fontana · 2026 · Molecular Pharmacology
  26. New and emerging therapeutics and molecular targets for attention-deficit hyperactivity disorder
    J. Haavik · 2026 · Expert opinion on therapeutic targets
  27. BindingDB Entry 50042867: Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at¿-aminobutyric acid type A (GABA(A)) receptor.
    BindingDB · 2013 · UC San Diego